Filing Details
- Accession Number:
- 0001062993-22-024356
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2022-12-21 19:28:36
- Reporting Period:
- 2022-12-19
- Accepted Time:
- 2022-12-21 19:28:36
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1267565 | Collegium Pharmaceutical Inc | COLL | Pharmaceutical Preparations (2834) | 000000000 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1448914 | Thomas Michael Heffernan | C/O Collegium Pharmaceutical, Inc. 100 Technology Center Drive Stoughton MA 02072 | Yes | No | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2022-12-19 | 3,606 | $16.15 | 31,629 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2022-12-19 | 3,606 | $23.04 | 28,023 | No | 4 | S | Direct | |
| Common Stock | Acquisiton | 2022-12-20 | 33,758 | $16.15 | 61,781 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2022-12-20 | 33,758 | $23.08 | 28,023 | No | 4 | S | Direct | |
| Common Stock | Acquisiton | 2022-12-21 | 46,600 | $16.15 | 74,623 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2022-12-21 | 46,600 | $23.11 | 28,023 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | M | Direct | |
| No | 4 | S | Direct | |
| No | 4 | M | Direct | |
| No | 4 | S | Direct | |
| No | 4 | M | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Stock Option (Right to Purchase) | Disposition | 2022-12-19 | 3,606 | $0.00 | 3,606 | $16.15 |
| Common Stock | Stock Option (Right to Purchase) | Disposition | 2022-12-20 | 33,758 | $0.00 | 33,758 | $16.15 |
| Common Stock | Stock Option (Right to Purchase) | Disposition | 2022-12-21 | 46,600 | $0.00 | 46,600 | $16.15 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 105,399 | 2026-01-20 | No | 4 | M | Direct | |
| 71,641 | 2026-01-20 | No | 4 | M | Direct | |
| 25,041 | 2026-01-20 | No | 4 | M | Direct |
Footnotes
- The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 10, 2022.
- The price reported in column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $23.00 to $23.11, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the U.S. Securities and Exchange Commission (the "SEC"), upon request, full information regarding the number of shares sold at each separate price within the range set forth in footnote (2).
- The price reported in column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $23.00 to $23.33, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the SEC, upon request, full information regarding the number of shares sold at each separate price within the range set forth in footnote (3).
- The price reported in column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $23.00 to $23.40, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the SEC, upon request, full information regarding the number of shares sold at each separate price within the range set forth in footnote (4).
- The option, initially representing a right to purchase a total of 109,005 shares, is fully vested and exercisable.
Billionaire Hedge Funds
